Guselkumab 100 mg Every 8 Weeks Consistently Improves Joint, Skin Through Week 24
The COSMOS trial showed guselkumab every 8 weeks improved PsA outcomes through week 48, including in patients with inadequate responses to TNF inhibitors.
Related Articles
Study Highlights Comorbidities Before, After Bullous Pemphigoid Diagnosis
In this case–control study, investigators identified relevant comorbidities among individuals with bullous pemphigoid before and after their diagnoses.
Why Oura Ring 4 is ZDNET’s product of the year – besting Samsung, Apple, and others in 2024
By blending precision health tracking with a refined design, the Oura Ring 4 underscores the growing importance of health tech in our daily lives.
ASML CEO says China is 10 to 15 years behind in chipmaking capabilities
ASML CEO says China is 10 to 15 years behind in chipmaking capabilities
How do you ward off the ‘whooping cough’? | Fox News Video
Fox News senior medical analyst Dr. Marc Siegel discusses the CDC reporting a six-fold increase in whooping cough cases on ‘Special Report.’
Stem cell therapy to correct heart failure in children could ‘transform lives’
Doctors and specialists at the Murdoch Children’s Research Institute in Melbourne, Australia, are studying and reprogramming the potential of the blood to treat heart failure…
Federal and State Governments Can Reduce Roadblocks to Methadone Access
In 2023, just 18% of people with an opioid use disorder (OUD) received any medication to treat it, despite the availability of therapies that have…
Biotechnologist and molecular biologist Xiao Wang seeks to understand the life cycle of cellular RNA
The challenges of transitioning from a postdoc to a PI and more from Dr. Wang.Â
The Worst Hacks of 2024
From Chinese cyberspies breaching US telecoms to ruthless ransomware gangs disrupting health care for millions of people, 2024 saw some of the worst hacks, breaches,…
CDC says H5N1 bird flu sample shows mutations that may help the virus bind to cells in the upper airways of people
The CDC said Thursday that the mutations, detected in a sample taken from a Louisiana patient, may help bind the virus to the upper airways…
